Using bioinformatics methods to elucidate fatty acid-binding protein 4 as a potential biomarker for colon adenocarcinoma

Figure 2 Relationships between fatty acid-binding protein 4 expression and clinical factors in patients with colon adenocarcinoma and Kaplan-Meier survival analysis of patients stratified according to fatty acid-binding protein 4 expression. A: The relationships between fatty acid-binding protein 4 (FABP4) expression and various clinical factors are ranked in ascending order of FABP4 expression; B: Kaplan-Meier survival curves of the FABP4 high-expression group and low-expression group. The cutoff for each group was the median expression of FABP4. COAD: Colon adenocarcinoma.